Correction to: TGF-beta1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4(+)Foxp3(+) regulatory T cells (Cellular & Molecular Immunology, (2010), 7, 1, (35-43), 10.1038/cmi.2009.107);TGF-Β1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4+ Foxp3+ regulatory T cells

Cellular and Molecular Immunology

Volumn 7, Issue 1, 2010, Pages 35-43

  Cai, Zhijian ^a   Zhang, Wei ^a   Li, Min ^a   Yue, Yinpu ^a   Yang, Fei ^a   Yu, Lei ^a   Cao, Xuetao ^a,b   Wang, Jianli ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

DCs; IBD; TGF b1; Treg

Indexed keywords

CD4 ANTIGEN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; DEXTRAN SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; DENDRITIC CELL; ENTERITIS; FEMALE; GENE; HISTOPATHOLOGY; LYMPH NODE; MESENTERY; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; CYTOLOGY; GENETICS; IMMUNOLOGY; PATHOLOGY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; FLUORESCENCE ACTIVATED CELL SORTER; IN VITRO STUDY; INFLAMMATION; MESENTERY LYMPH NODE; THERAPY EFFECT;

MUS;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; INFLAMMATORY BOWEL DISEASES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 75949104055     PISSN: 16727681     EISSN: 20420226     Source Type: Journal    
DOI: 10.1038/s41423-019-0338-6     Document Type: Erratum

References (23)

1. Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel diseases. Annu Rev Med 2000; 51: 289-298.
2. Loftus EV JrClinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-1517.
3. Yu Y, Sitaraman S, Gewirtz AT. Intestinal epithelial cell regulation of mucosal inflammation. Immunol Res 2004; 29: 55-68.
4. Kuhbacher T, Fölsch UR. Practical guidelines for the treatment of inflammatory bowel disease. World J Gastroenterol 2007; 13: 1149-1155.
5. Pepper MS. Transforming growth factor-beta: vasculogenesis, angiogenesis and vessel wall integrity. Cytokine Growth Factor Rev 1997; 8: 21-43.
6. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000; 342: 1350-1358.
7. Lawrance IC, Maxwell L, Doe W. Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collagen deposition in IBD intestine. Inflamm Bowel Dis 2001; 7: 16-26.
8. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 192: 245-252.
9. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21: 685-711.
10. Wallet MA, Sen P, Tisch R. Immunoregulation of dendritic cells. Clin Med Res 2005; 3: 166-175.
11. Zhang MH, Tang H, Guo ZH, An HZ, Zhu XJ, Song WG et al. Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat Immunol 2004; 5: 1124-1133.
12. Aharonia R, Sonegoa H, Brennerb O, Eilamb R, Arnon R. The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells. J Pharmacol Exp Ther 2006; 318: 68-78.
13. Sun WJ, Wang QX, Zhang LH, Pan JP, Zhang M, Lu GH et al. TGF-b1 gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo. J Mol Med 2002; 80: 514-523.
14. Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997; 159: 4772-4780.
15. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3: 133-146.
16. Wing K, Fehervari Z, Sakaguchi S. Emerging possibilities in the development and function of regulatory T cells. Int Immunol 2006; 18: 991-1000.
17. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417-429.
18. Leehler R, Ng WF, Steinman RM. Dendritic cells in transplantation: friend or foe? Immunity 2001; 14: 357-368.
19. Jong EC, Smits HH, Kapsenberg ML. Dendritic cell-mediated T cell polarization. Springer Semin Immunopathol 2005; 26: 289-307.
20. Thomson AW, Lu L, Murase N, Demetris AJ, Rao AS, Starzl TE. Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells 1995; 13: 622-639.
21. Placek K, Coffre M, Maiella S, Bianchi E, Rogge L. Genetic and epigenetic networks controlling T helper 1 cell differentiation. Immunology 2009; 127: 155-162.
22. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69: 238-249.
23. Sauer S, Bruno L, Hertweck A, Finlay D, Leleu M, Spivakov M et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci USA 2008; 105: 7797-7802.